racecadotril has been researched along with atrial natriuretic factor in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (5.56) | 18.7374 |
1990's | 14 (77.78) | 18.2507 |
2000's | 3 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Duboc, D; Fouchard, J; Guérin, F; Muffat-Joly, M; Schwartz, JC; Varin, J; Weber, S | 1 |
Ardaillou, R; Bodin, F; Dussaule, JC; Grangé, JD; Gros, C; Lecomte, JM; Schwartz, JC; Wolf, JP | 1 |
Hirata, Y | 1 |
Bralet, J; Danvy, D; Duhamel, L; Duhamel, P; Gros, C; Lecomte, JM; Noël, N; Plaquevent, JC; Schwartz, JC; Souque, A | 1 |
Castaigne, A; Duboc, D; Dubois-Rande, JL; Gros, C; Kahn, JC; Lecomte, JM; Lim-Alexandre, C; Merlet, P; Patey, M; Schwartz, JC | 1 |
Gros, C; Schwartz, JC; Souque, A | 2 |
Bralet, J; Charpentier, S; Gros, C; Lecomte, JM; Mossiat, C; Schwartz, JC | 1 |
Ardaillou, R; Baumer, P; Chaignon, B; Cournot, A; Duchier, J; Dussaule, JC; Gros, C; Lecomte, JM; Lim, C; Souque, A | 1 |
Baumer, P; Cournot, A; Duchier, J; Gros, C; Lecomte, JM; Schwartz, JC; Souque, A | 1 |
Hirth-Dietrich, C; Knorr, A; Stasch, JP; Wegner, M | 1 |
Brouard, R; Brunner, HR; Burnier, M; Favrat, B; Lecomte, JM; Nussberger, J; Waeber, B | 1 |
Ardaillou, R; Dussaule, JC; Gros, C; Lecomte, JM; Michel, C; Mignon, F; Peraldi, MN | 1 |
Berry, CJ; Fink, CA; Ghai, RD; Qiao, Y; Sakane, Y; Trapani, AJ | 1 |
Hirth-Dietrich, C; Stasch, JP; Wegner, M | 1 |
Goetze, L; Sisson, D; Solter, P; Thomas, W | 1 |
Brandenberger, G; Charloux, A; Doutreleau, S; Geny, B; Hannedouche, T; Piquard, F; Richard, R | 1 |
Baliga, RS; Hobbs, AJ; Lopez-Torondel, B; MacAllister, RJ; Madhani, M; Selwood, D; Visintin, C; Wilkins, MR; Zhao, L | 1 |
1 review(s) available for racecadotril and atrial natriuretic factor
Article | Year |
---|---|
[Effect of sinorphan, an endopeptidase inhibitor on severe congestive cardiac insufficiency].
Topics: Adult; Aged; Atrial Natriuretic Factor; Blood Pressure; Creatinine; Cyclic GMP; Diuresis; Female; Heart Failure; Humans; Male; Middle Aged; Natriuresis; Neprilysin; Thiorphan | 1991 |
8 trial(s) available for racecadotril and atrial natriuretic factor
Article | Year |
---|---|
[Effect of sinorphan, an endopeptidase inhibitor on severe congestive cardiac insufficiency].
Topics: Adult; Aged; Atrial Natriuretic Factor; Blood Pressure; Creatinine; Cyclic GMP; Diuresis; Female; Heart Failure; Humans; Male; Middle Aged; Natriuresis; Neprilysin; Thiorphan | 1991 |
Effect of sinorphan, an enkephalinase inhibitor, on plasma atrial natriuretic factor and sodium urinary excretion in cirrhotic patients with ascites.
Topics: Administration, Oral; Adult; Aldosterone; Atrial Natriuretic Factor; Cyclic GMP; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Humans; Liver Cirrhosis; Male; Middle Aged; Neprilysin; Renin; Sodium; Thiorphan | 1991 |
Effect of sinorphan on plasma atrial natriuretic factor in congestive heart failure.
Topics: Administration, Oral; Atrial Natriuretic Factor; Clinical Trials as Topic; Drug Administration Schedule; Heart Failure; Humans; Male; Neprilysin; Stimulation, Chemical; Thiorphan | 1990 |
Stereoselective protection of exogenous and endogenous atrial natriuretic factor by enkephalinase inhibitors in mice and humans.
Topics: Administration, Oral; Adult; Animals; Atrial Natriuretic Factor; Binding, Competitive; Chemical Phenomena; Chemistry; Cyclic GMP; Double-Blind Method; Humans; Injections, Intravenous; Kidney; Male; Mice; Neprilysin; Random Allocation; Thiorphan; Time Factors | 1990 |
Protection of atrial natriuretic factor against degradation: diuretic and natriuretic responses after in vivo inhibition of enkephalinase (EC 3.4.24.11) by acetorphan.
Topics: Animals; Atrial Natriuretic Factor; Diuresis; Humans; Hydrolysis; Kidney; Kinetics; Male; Mice; Natriuresis; Neprilysin; Thiorphan | 1989 |
Neutral endopeptidase versus angiotensin converting enzyme inhibition in essential hypertension.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Blood Pressure; Captopril; Cross-Over Studies; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Neprilysin; Protease Inhibitors; Thiorphan | 1995 |
Inhibition of neutral endopeptidase stimulates renal sodium excretion in patients with chronic renal failure.
Topics: Adult; Aged; Aged, 80 and over; Atrial Natriuretic Factor; Cyclic GMP; Double-Blind Method; Female; Humans; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Neprilysin; Sodium; Sodium, Dietary; Thiorphan; Time Factors | 1993 |
Hormonal, renal, hemodynamic responses to acute neutral endopeptidase inhibition in heart transplant patients.
Topics: Adult; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Cyclosporine; Double-Blind Method; Endothelin-1; Glomerular Filtration Rate; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Natriuresis; Neprilysin; Protease Inhibitors; Renal Circulation; Thiorphan; Vascular Resistance | 2002 |
10 other study(ies) available for racecadotril and atrial natriuretic factor
Article | Year |
---|---|
[Clinical significance and therapeutic application of atrial natriuretic peptides].
Topics: Animals; Atrial Natriuretic Factor; Glycopeptides; Heart Atria; Heart Failure; Hemodynamics; Humans; Receptors, Atrial Natriuretic Factor; Receptors, Cell Surface; Thiorphan | 1991 |
Mixed inhibitors of angiotensin-converting enzyme (EC 3.4.15.1) and enkephalinase (EC 3.4.24.11): rational design, properties, and potential cardiovascular applications of glycopril and alatriopril.
Topics: Alanine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Pressure; Cell Membrane; Cyclic GMP; Dioxoles; Dipeptides; Diuresis; Glycine; Humans; Lung; Male; Mice; Molecular Structure; Natriuresis; Neprilysin; Peptidyl-Dipeptidase A; Rats; Rats, Inbred Strains; Thiorphan | 1991 |
Inactivation of atrial natriuretic factor in mice in vivo: crucial role of enkephalinase (EC 3.4.24.11).
Topics: Administration, Oral; Animals; Atrial Natriuretic Factor; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Iodine Radioisotopes; Kidney; Male; Mice; Neprilysin; Protease Inhibitors; Thiorphan; Time Factors | 1990 |
Diuretic and natriuretic responses in rats treated with enkephalinase inhibitors.
Topics: Animals; Atrial Natriuretic Factor; Chromatography, High Pressure Liquid; Diuresis; Injections, Intravenous; Male; Natriuresis; Neprilysin; Potassium; Prodrugs; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Thiorphan; Time Factors | 1990 |
Degradation of atrial natriuretic factor in mouse blood in vitro and in vivo: role of enkephalinase (EC 3.4.24.11).
Topics: Animals; Atrial Natriuretic Factor; Chromatography, High Pressure Liquid; Half-Life; Hydrolysis; In Vitro Techniques; Iodine Radioisotopes; Male; Metabolic Clearance Rate; Mice; Neprilysin; Thiorphan | 1990 |
Prolonged inhibition of neutral endopeptidase 24.11 by sinorphan in stroke-prone spontaneously hypertensive rats.
Topics: Animals; Atrial Natriuretic Factor; Blood Pressure; Body Weight; Heart Failure; Hemodynamics; Kidney Function Tests; Neprilysin; Rats; Rats, Inbred SHR; Sodium, Dietary; Thiorphan; Time Factors | 1995 |
New alpha-thiol dipeptide dual inhibitors of angiotensin-I converting enzyme and neutral endopeptidase EC 3.4.24.11.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Pressure; Captopril; Dipeptides; Magnetic Resonance Spectroscopy; Male; Neprilysin; Peptidyl-Dipeptidase A; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Sulfhydryl Compounds; Thiorphan; Tryptophan | 1995 |
Role of neutral endopeptidase 24.11 in AV fistular rat model of heart failure.
Topics: Angiotensin I; Animals; Aorta; Arteriovenous Fistula; Atrial Natriuretic Factor; Disease Models, Animal; Heart Failure; Natriuretic Peptide, Brain; Neprilysin; Nerve Tissue Proteins; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Renin; Sodium; Thiorphan; Venae Cavae | 1996 |
Intrarenal effects of ecadotril during acute volume expansion in dogs with congestive heart failure.
Topics: Animals; Atrial Natriuretic Factor; Dogs; Glomerular Filtration Rate; Heart Failure; Kidney; Male; Neprilysin; Protease Inhibitors; Renal Circulation; Thiorphan | 2000 |
Synergy between natriuretic peptides and phosphodiesterase 5 inhibitors ameliorates pulmonary arterial hypertension.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Atrial Natriuretic Factor; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Hypertension, Pulmonary; Male; Neprilysin; Piperazines; Protease Inhibitors; Pulmonary Artery; Purines; Rats; Rats, Sprague-Dawley; Sildenafil Citrate; Sulfones; Thiorphan; Treatment Outcome; Vascular Resistance; Vasodilation; Vasodilator Agents | 2008 |